Alessandro Noseda
Direttore/Membro del Consiglio presso REGENERX BIOPHARMACEUTICALS, INC.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Alessandro Noseda is an Independent Director at RegeneRx Biopharmaceuticals, Inc. He is also a Director at Metheresis Translational Research SA, Thule Therapeutics SA, and Rostaquo.
Previously, he served as the Chief Medical Officer at Leadiant Biosciences, Inc. from 1998 to the present.
He also held the position of Chief Scientific Officer at Leadiant Biosciences SpA from 2007 to the present.
Prior to that, he was the Chief Executive Officer at Leadiant Biosciences SA from 2007 to 2017.
Dr. Noseda holds a doctorate degree from Wake Forest School of Medicine and the University of Milan, which he received in 1984.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 15/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Alessandro Noseda
| Società | Posizione | Inizio |
|---|---|---|
| REGENERX BIOPHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/04/2019 |
Leadiant Biosciences SpA
 Leadiant Biosciences SpA Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Leadiant Biosciences SpA develops and manufactures pharmaceutical therapies for patients with rare diseases. The company is based in Rome, Italy. The Italian company was founded in 1957. Marco Maria Brughera has been the CEO of the company since 2011. Leadiant Biosciences was acquired by CHIESI Farmaceutici SpA on October 20, 2020. | Direttore Tecnico/Scientifico/R&S | 01/01/2014 |
Leadiant Biosciences, Inc.
 Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Direttore Tecnico/Scientifico/R&S | 01/09/2018 |
| Thule Therapeutics SA | Direttore/Membro del Consiglio | - |
| Rostaquo | Direttore/Membro del Consiglio | - |
| Metheresis Translational Research SA | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Alessandro Noseda
| Società | Posizione | Fine |
|---|---|---|
Leadiant Biosciences SA
 Leadiant Biosciences SA Miscellaneous Commercial ServicesCommercial Services Leadiant Biosciences SA conducts biotechnological research. | Amministratore Delegato | 01/01/2017 |
Formazione di Alessandro Noseda
| University of Milan | Doctorate Degree |
| Wake Forest School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| REGENERX BIOPHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 6 |
|---|---|
Leadiant Biosciences SpA
Leadiant Biosciences SpA Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Leadiant Biosciences SpA develops and manufactures pharmaceutical therapies for patients with rare diseases. The company is based in Rome, Italy. The Italian company was founded in 1957. Marco Maria Brughera has been the CEO of the company since 2011. Leadiant Biosciences was acquired by CHIESI Farmaceutici SpA on October 20, 2020. | Health Technology |
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Health Technology |
Leadiant Biosciences SA
Leadiant Biosciences SA Miscellaneous Commercial ServicesCommercial Services Leadiant Biosciences SA conducts biotechnological research. | Commercial Services |
| Thule Therapeutics SA | |
| Rostaquo | |
| Metheresis Translational Research SA |
- Borsa valori
- Insiders
- Alessandro Noseda
